B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a Hodgkin lymphoma expressing functional B-cell receptors (BCR). Recently, we described a dual stimulation model of IgD+ lymphocyte-predominant cells by Moraxella catarrhalis antigen RpoC and its superantigen MID/hag, associated with extralong CDR3 and HLA-DRB1*04 or HLADRB1* 07 haplotype. The aim of the present study was to extend the antigen screening to further bacteria and viruses. The fragment antibody-binding (Fab) regions of seven new and 15 previously reported cases were analyzed. The reactivity of non-Moraxella spp.-reactive Fab regions against lysates of Rothia mucilaginosa was observed in 5/22 (22.7%) cases. Galactofuranosyl transferase (Gltf) and 2,3-butanediol dehydrogenase (Bdh) of R. mucilaginosa were identified by comparative silver- and immuno-staining in two-dimensional gels, with subsequent mass spectrometry and validation by western blots and enzyme-linked immunosorbent assay. Both R. mucilaginosa Gltf and Bdh induced BCR pathway activation and proliferation in vitro. Apoptosis was induced by recombinant Gltf/ETA'-immunotoxin conjugates in DEV cells expressing recombinant R. mucilaginosa-reactive BCR. Reactivity against M. catarrhalis RpoC was confirmed in 3/7 newly expressed BCR (total 10/22 reactive to Moraxella spp.), resulting in 15/22 (68.2%) cases with BCR reactivity against defined bacterial antigens. These findings strengthen the hypothesis of bacterial trigger contributing to subsets of NLPHL.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:108 |
---|---|
Enthalten in: |
Haematologica - 108(2023), 12 vom: 01. Dez., Seite 3347-3358 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Thurner, Lorenz [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 04.12.2023 Date Revised 05.12.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3324/haematol.2023.282698 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356428826 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356428826 | ||
003 | DE-627 | ||
005 | 20231226070436.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3324/haematol.2023.282698 |2 doi | |
028 | 5 | 2 | |a pubmed24n1188.xml |
035 | |a (DE-627)NLM356428826 | ||
035 | |a (NLM)37139600 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Thurner, Lorenz |e verfasserin |4 aut | |
245 | 1 | 0 | |a B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.12.2023 | ||
500 | |a Date Revised 05.12.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a Hodgkin lymphoma expressing functional B-cell receptors (BCR). Recently, we described a dual stimulation model of IgD+ lymphocyte-predominant cells by Moraxella catarrhalis antigen RpoC and its superantigen MID/hag, associated with extralong CDR3 and HLA-DRB1*04 or HLADRB1* 07 haplotype. The aim of the present study was to extend the antigen screening to further bacteria and viruses. The fragment antibody-binding (Fab) regions of seven new and 15 previously reported cases were analyzed. The reactivity of non-Moraxella spp.-reactive Fab regions against lysates of Rothia mucilaginosa was observed in 5/22 (22.7%) cases. Galactofuranosyl transferase (Gltf) and 2,3-butanediol dehydrogenase (Bdh) of R. mucilaginosa were identified by comparative silver- and immuno-staining in two-dimensional gels, with subsequent mass spectrometry and validation by western blots and enzyme-linked immunosorbent assay. Both R. mucilaginosa Gltf and Bdh induced BCR pathway activation and proliferation in vitro. Apoptosis was induced by recombinant Gltf/ETA'-immunotoxin conjugates in DEV cells expressing recombinant R. mucilaginosa-reactive BCR. Reactivity against M. catarrhalis RpoC was confirmed in 3/7 newly expressed BCR (total 10/22 reactive to Moraxella spp.), resulting in 15/22 (68.2%) cases with BCR reactivity against defined bacterial antigens. These findings strengthen the hypothesis of bacterial trigger contributing to subsets of NLPHL | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Receptors, Antigen, B-Cell |2 NLM | |
700 | 1 | |a Fadle, Natalie |e verfasserin |4 aut | |
700 | 1 | |a Regitz, Evi |e verfasserin |4 aut | |
700 | 1 | |a Roth, Sophie |e verfasserin |4 aut | |
700 | 1 | |a Cetin, Onur |e verfasserin |4 aut | |
700 | 1 | |a Kos, Igor Age |e verfasserin |4 aut | |
700 | 1 | |a Hess, Simon Mauro |e verfasserin |4 aut | |
700 | 1 | |a Bein, Julia |e verfasserin |4 aut | |
700 | 1 | |a Bohle, Rainer Maria |e verfasserin |4 aut | |
700 | 1 | |a Vornanen, Martine |e verfasserin |4 aut | |
700 | 1 | |a Sundström, Christer |e verfasserin |4 aut | |
700 | 1 | |a De Leval, Laurence |e verfasserin |4 aut | |
700 | 1 | |a Tiacci, Enrico |e verfasserin |4 aut | |
700 | 1 | |a Borchmann, Peter |e verfasserin |4 aut | |
700 | 1 | |a Engert, Andreas |e verfasserin |4 aut | |
700 | 1 | |a Poeschel, Viola |e verfasserin |4 aut | |
700 | 1 | |a Held, Gerhard |e verfasserin |4 aut | |
700 | 1 | |a Schwarz, Eva C |e verfasserin |4 aut | |
700 | 1 | |a Neumann, Frank |e verfasserin |4 aut | |
700 | 1 | |a Preuss, Klaus-Dieter |e verfasserin |4 aut | |
700 | 1 | |a Hoth, Markus |e verfasserin |4 aut | |
700 | 1 | |a Küppers, Ralf |e verfasserin |4 aut | |
700 | 1 | |a Lehman, Karola |e verfasserin |4 aut | |
700 | 1 | |a Hansmann, Martin-Leo |e verfasserin |4 aut | |
700 | 1 | |a Becker, Sören L |e verfasserin |4 aut | |
700 | 1 | |a Bewarder, Moritz |e verfasserin |4 aut | |
700 | 1 | |a Hartmann, Sylvia |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Haematologica |d 1947 |g 108(2023), 12 vom: 01. Dez., Seite 3347-3358 |w (DE-627)NLM000081892 |x 1592-8721 |7 nnns |
773 | 1 | 8 | |g volume:108 |g year:2023 |g number:12 |g day:01 |g month:12 |g pages:3347-3358 |
856 | 4 | 0 | |u http://dx.doi.org/10.3324/haematol.2023.282698 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 108 |j 2023 |e 12 |b 01 |c 12 |h 3347-3358 |